Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-7-1
|
pubmed:abstractText |
We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0315-162X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
621-2
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:1350640-Adult,
pubmed-meshheading:1350640-Agranulocytosis,
pubmed-meshheading:1350640-Arthritis, Rheumatoid,
pubmed-meshheading:1350640-Bone Marrow,
pubmed-meshheading:1350640-Female,
pubmed-meshheading:1350640-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:1350640-Humans,
pubmed-meshheading:1350640-Sulfasalazine
|
pubmed:year |
1992
|
pubmed:articleTitle |
Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
|
pubmed:affiliation |
Department of Internal Medicine, University Hospital, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|